The paradox of pro-inflammatory cytokines in cancer
- 23 September 2006
- journal article
- review article
- Published by Springer Science and Business Media LLC in Cancer and Metastasis Reviews
- Vol. 25 (3), 307-313
- https://doi.org/10.1007/s10555-006-9000-8
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- CD11b+/Gr-1+ Immature Myeloid Cells Mediate Suppression of T Cells in Mice Bearing Tumors of IL-1β-Secreting CellsThe Journal of Immunology, 2005
- Targeting Myelomonocytic Cells to Revert Inflammation-Dependent Cancer PromotionCancer Research, 2005
- Inflammation by remote controlNature, 2005
- Smoldering and polarized inflammation in the initiation and promotion of malignant diseaseCancer Cell, 2005
- Allele 2 of the Interleukin-1 Receptor Antagonist Gene Is Associated With Early Gastric CancerJournal of Clinical Oncology, 2004
- Tuberculosis following the Use of Etanercept, a Tumor Necrosis Factor InhibitorClinical Infectious Diseases, 2004
- Granulomatous Infectious Diseases Associated with Tumor Necrosis Factor AntagonistsClinical Infectious Diseases, 2004
- Anakinra, a recombinant human interleukin‐1 receptor antagonist (r‐metHuIL‐1ra), in patients with rheumatoid arthritis: A large, international, multicenter, placebo‐controlled trialArthritis & Rheumatism, 2003
- Correction: The role of interleukin-1 polymorphisms in the pathogenesis of gastric cancerNature, 2001
- Interleukin 1 Polymorphisms, Lifestyle Factors, andHelicobacter pyloriInfectionJapanese Journal of Cancer Research, 2001